We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA APPROVES GENERIC VERSIONS OF POPULAR THYROID TREATMENTS
FDA APPROVES GENERIC VERSIONS OF POPULAR THYROID TREATMENTS
June 24, 2004
The FDA has given several generic firms the green light to start marketing versions of the widely used levothyroxine sodium thyroid treatments.